“At the end of 2015 we will have the final results of the tests of our vaccine. Then, it is necessary to obtain additional documents to allow it to be used on humans. It must first be registered in Russia, which also takes some time. We hope that the vaccine will be ready for mass use by early 2016,” Shevyreva told a RIA Novosti correspondent.
Shevyreva noted that pre-clinical trials of the vaccine are currently underway.
No vaccines against Ebola are currently licensed for use on humans, though clinical trials of two vaccine candidates are underway.
Several countries have intensified their efforts to find a vaccine against the deadly virus after the beginning of the Ebola outbreak in West Africa last year, which has claimed the lives of more than 8,600 people, according to the latest WHO estimates.